| Jan 5, 2025 |
Jan 7, 2025 |
Biohaven Ltd.
|
Chief Scientific Officer |
Sell |
42.5
|
-2,331
|
-6.28%
|
✗
|
$90.1K |
| Jun 17, 2024 |
Jun 20, 2024 |
Biohaven Ltd.
|
Chief Scientific Officer |
Buy |
100.0
|
+30,000
|
1258.92%
|
✗
|
$1M |
| Feb 18, 2022 |
Feb 23, 2022 |
AGIOS PHARMACEUTICALS, INC.
|
Chief Scientific Officer |
Sell |
22.5
|
-2,041
|
-10.86%
|
✗
|
$59.4K |
| Feb 10, 2022 |
Feb 14, 2022 |
AGIOS PHARMACEUTICALS, INC.
|
Chief Scientific Officer |
Sell |
26.3
|
-1,073
|
-8.26%
|
✗
|
$33.7K |
| Jan 6, 2022 |
Jan 10, 2022 |
AGIOS PHARMACEUTICALS, INC.
|
Chief Scientific Officer |
Sell |
26.3
|
-1,205
|
-11.44%
|
✗
|
$39.3K |
| Jan 6, 2021 |
Apr 15, 2021 |
AGIOS PHARMACEUTICALS, INC.
|
Chief Scientific Officer |
Sell |
22.5
|
-1,191
|
-14.38%
|
✗
|
$52.5K |
| Apr 13, 2020 |
Apr 15, 2020 |
AGIOS PHARMACEUTICALS, INC.
|
Chief Scientific Officer |
Sell |
22.5
|
-2,027
|
-29.49%
|
✗
|
$82.4K |